Home Cart 0 Sign in  

[ CAS No. 92050-16-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 92050-16-3
Chemical Structure| 92050-16-3
Structure of 92050-16-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 92050-16-3 ]

Related Doc. of [ 92050-16-3 ]

Alternatived Products of [ 92050-16-3 ]

Product Details of [ 92050-16-3 ]

CAS No. :92050-16-3 MDL No. :MFCD12828202
Formula : C14H21N Boiling Point : -
Linear Structure Formula :- InChI Key :AMDKYPNODLTUMY-UHFFFAOYSA-N
M.W : 203.32 Pubchem ID :11469760
Synonyms :

Calculated chemistry of [ 92050-16-3 ]

Physicochemical Properties

Num. heavy atoms : 15
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.57
Num. rotatable bonds : 0
Num. H-bond acceptors : 0.0
Num. H-bond donors : 1.0
Molar Refractivity : 67.27
TPSA : 26.02 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -4.44 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.53
Log Po/w (XLOGP3) : 4.37
Log Po/w (WLOGP) : 3.63
Log Po/w (MLOGP) : 3.48
Log Po/w (SILICOS-IT) : 3.64
Consensus Log Po/w : 3.53

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.15
Solubility : 0.0144 mg/ml ; 0.0000708 mol/l
Class : Moderately soluble
Log S (Ali) : -4.63
Solubility : 0.00474 mg/ml ; 0.0000233 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -4.68
Solubility : 0.00426 mg/ml ; 0.0000209 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 1.87

Safety of [ 92050-16-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 92050-16-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 92050-16-3 ]
  • Downstream synthetic route of [ 92050-16-3 ]

[ 92050-16-3 ] Synthesis Path-Upstream   1~14

  • 1
  • [ 102121-55-1 ]
  • [ 92050-16-3 ]
YieldReaction ConditionsOperation in experiment
99% With palladium 10% on activated carbon; hydrogen In ethyl acetate at 70℃; a. 5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalen-2-amine (74). A 0.05 M solution of1,1 ,4,4-tetramethyl-6-nitro- 1,2,3 ,4-tetrahydronaphthalene (73) (2.5 g, 10.7 mmol) in ethyl acetate(210 mL) was passed through a 10percent PdJC cartridge at 1.0 mL/minute, twice, in the ThalesNano Hcube® at 70 °C and 2-5 bar pressure. The resulting solution was concentrated in vacuo to give 74(2.1532 g, 99percent) as a yellow, crystalline solid, m.p. 58-60 °C: ‘H NMR (400 MHz, CDC13) 7.11 (d, J= 8.4, 1H), 6.65 (d, J= 2.4, 1H), 6.54 (dd, J= 8.4, 2.4, ill), 3.62 (br s, 2H), 1.66 (s, 4H), 1.26 (s, 611), 1.25 (s, 611); ‘3C NMR (100.6 MHz, CDC13) ö 145.8, 143.3, 135.4, 127.3, 113.7, 112.9, 35.2,34.1, 33.5, 31.9, 31.7; IR (neat) 3405, 3208, 2952, 2920, 1612, 1499 cm’; LC-MS-CI (M+H)+ calcd for C,4H22N 204.1752, found 204.1747.
99% With palladium 10% on activated carbon; hydrogen In ethyl acetate at 70℃; Flow reactor A 0.05 M solution of 1,1,4,4-tetramethyl-6-nitro-1,2,3,4-tetrahydronaphthalene (32) (2.5 g, 10.7 mmol) in ethyl acetate (210 mL) was passed through a 10percent Pd/C cartridge at 1.0 mL/minute, twice, in the ThalesNano H-cube® at 70° C. and 2-5 bar pressure.
The resulting solution was concentrated in vacuo to give compound 33 (2.1532 g, 99percent) as a yellow, crystalline solid, m.p. 58-60° C.: 1H NMR (400 MHz, CDCl3) δ 7.11 (d, J=8.4, 1H), 6.65 (d, J=2.4, 1H), 6.54 (dd, J=8.4, 2.4, 1H), 3.62 (br s, 2H), 1.66 (s, 4H), 1.26 (s, 6H), 1.25 (s, 6H); 13C NMR (100.6 MHz, CDCl3) δ 145.8, 143.3, 135.4, 127.3, 113.7, 112.9, 35.2, 34.1, 33.5, 31.9, 31.7; IR (neat) 3405, 3208, 2952, 2920, 1612, 1499 cm-1; LC-MS-CI (M+H)+ calcd for C14H22N 204.1752, found 204.1747.
75% With iron; calcium chloride In ethanol at 78℃; Inert atmosphere To a solution of nitro-1,2,3,4-tetrahydronaphthalenes 30(5.0 mmol) in 95percent ethanol (35 mL mmol-1), powdered iron(150 mmol) and CaCl2 (50 mmol) were added. The mixturewas refluxed at 78 °C for 48 h. The reaction mixture wasextracted with ethyl acetate and the organic phase dried overanhydrous MgSO4. The solvent was then removed undervacuum. The product was purified by flash chromatographyusing hexane/ethyl acetate 90:10 as eluent. The product 31was obtained as a brown crystal in 75percent yield. mp 71 °C;1H NMR (300 MHz, CDCl3) δ 1.21 (s, 6H, 2CH3), 1.23 (s,6H, 2CH3), 1.62 (s, 4H, CH2), 3.48 (ls, 2H, NH2), 6.61 (d,1H, J 2.7 Hz, Ar-H), 6.50 (dd, 1H, J 8.1, 2.7 Hz, Ar-H),7.08 (d, 1H, J 8.1 Hz, Ar-H); 13C NMR (75 MHz, CDCl3) δ 31.80, 32.00, 33.53, 34.20, 35.23, 112.88, 113.62, 127.37,135.38, 143.58, 145.82.
46% With iron; acetic acid In water at 60℃; for 3.25 h; A mixture of HNO3 [63percent] (0.94 mL) and H2SO4 (1.5 mL) was added to 1,1,4,4-tetramethyl-1,2,3,4-tetrahydro-naphthalene5 (2.0 g, 10.6 mmol) at -10°C and the reaction mixture was stirred for 1 h. The reaction mixture was poured into ice:water and the product was extracted with CH2Cl2. The organic layer was washed with NaOH (1N), H2O, brine, dried over MgSO4 to give after solvent evaporation 1,1,4,4-tetramethyl-6-nitro-1,2,3,4-tetrahydro-naphthalene (1.87 g, 76 percent). ref. Kagechika, H., Kawachi, E., Hashimoto, Y., Shudo, K., Himi T., J. Med. Chem., 31, 2182-2192, 1988. To a stirred solution of 1,1,4,4-tetramethyl-6-nitro-1,2,3,4-tetrahydro-naphthalene (0.593 g, 2.5 mmol) in glacial acetic acid ( 10 mL) was added iron powder (0.77, 13.8 mmol) over a period of 15 min. The reaction mixture was stirred at 60°C for 3 hours. The volatiles were evaporated and the resulting oil was partitioned between EtOAc and water. Organics extracts were washed with brine, dried over MgSO4 to obtain 5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-2-ylamine6 (0.232 g, 46percent yield) as a brown solid. [] MW: 203.32; Yield: 35 percent; Brown Solid; Mp (°C): 67.1H NMR (CDCl3,δ): 1.23 (s, 6H, 2xCH3), 1.25 (s, 6H, 2xCH3), 1.64 (s, 4H, 2xCH2), 3.50 (s, 2H, NH2), 6.52 (dd, 1H, J = 8.32 Hz, J = 2.53 Hz, ArH), 6.63 (d, 1H, J = 2.52 Hz, ArH), 7.10 (d, 1H, J = 8.33 Hz, ArH).MS-ESI: m/z (rel. int.) 204.0 ([MH]+, 100).HPLC: Method A, detection 254 nm, RT = 4.8 min, Peak area 90 percent.

Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 9, p. 2352 - 2356
[2] Patent: WO2015/130973, 2015, A1, . Location in patent: Page/Page column 34; 35
[3] Journal of Medicinal Chemistry, 2016, vol. 59, # 19, p. 8924 - 8940
[4] Patent: US2018/207156, 2018, A1, . Location in patent: Paragraph 0114; 0119
[5] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 15, p. 7277 - 7290
[6] Organic Letters, 2013, vol. 15, # 6, p. 1378 - 1381
[7] Heterocycles, 2010, vol. 81, # 11, p. 2465 - 2470
[8] Journal of the Brazilian Chemical Society, 2018, vol. 29, # 1, p. 109 - 124
[9] Journal of Medicinal Chemistry, 1988, vol. 31, # 11, p. 2182 - 2192
[10] Patent: EP1541549, 2005, A1, . Location in patent: Page/Page column 15; 38
[11] Letters in Drug Design and Discovery, 2016, vol. 13, # 8, p. 729 - 733
  • 2
  • [ 6683-46-1 ]
  • [ 92050-16-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 9, p. 2352 - 2356
[2] Journal of Medicinal Chemistry, 1988, vol. 31, # 11, p. 2182 - 2192
[3] Patent: US4703110, 1987, A,
[4] Heterocycles, 2010, vol. 81, # 11, p. 2465 - 2470
[5] Organic Letters, 2013, vol. 15, # 6, p. 1378 - 1381
[6] Letters in Drug Design and Discovery, 2016, vol. 13, # 8, p. 729 - 733
  • 3
  • [ 139162-43-9 ]
  • [ 92050-16-3 ]
YieldReaction ConditionsOperation in experiment
70% With hydrogenchloride In water at 100℃; for 10.5 h; Compound (23) (2.50 g) obtained in Step 6-2 was added to a 6 N hydrochloric acid aqueous solution (50 mL), and the mixture was stirred at 100 ° C. for 10.5 hours. After returning to room temperature, the reaction solution was rendered alkaline with 6 N aqueous sodium hydroxide solution under ice cooling and extracted with diethyl ether.The organic layer was separated, washed with saturated brine, and dried with anhydrous sodium sulfate. After filtration and concentration under reduced pressure, the obtained residue was purified by silica gel flash column chromatography (developing solvent n-hexane: ethyl acetate = 4: 1) to give the title compound (24) (1.45 g, yield 70percent) as light As a brown solid.
Reference: [1] Patent: JP2017/71567, 2017, A, . Location in patent: Paragraph 0183-0184; 0187
  • 4
  • [ 6223-78-5 ]
  • [ 92050-16-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 9, p. 2352 - 2356
[2] Journal of Medicinal Chemistry, 1988, vol. 31, # 11, p. 2182 - 2192
[3] Journal of Organic Chemistry, 1960, vol. 25, p. 708 - 711
[4] Letters in Drug Design and Discovery, 2016, vol. 13, # 8, p. 729 - 733
[5] Patent: JP2017/71567, 2017, A,
[6] Journal of the Brazilian Chemical Society, 2018, vol. 29, # 1, p. 109 - 124
  • 5
  • [ 6683-46-1 ]
  • [ 92050-16-3 ]
Reference: [1] Patent: US2003/125383, 2003, A1,
  • 6
  • [ 110-03-2 ]
  • [ 92050-16-3 ]
Reference: [1] Journal of Medicinal Chemistry, 1988, vol. 31, # 11, p. 2182 - 2192
[2] Letters in Drug Design and Discovery, 2016, vol. 13, # 8, p. 729 - 733
[3] Patent: JP2017/71567, 2017, A,
[4] Journal of the Brazilian Chemical Society, 2018, vol. 29, # 1, p. 109 - 124
  • 7
  • [ 6683-46-1 ]
  • [ 92050-16-3 ]
  • [ 102121-55-1 ]
Reference: [1] Patent: US5087743, 1992, A,
[2] Patent: US5128479, 1992, A,
  • 8
  • [ 27452-17-1 ]
  • [ 92050-16-3 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 5, p. 748 - 753
  • 9
  • [ 103031-30-7 ]
  • [ 92050-16-3 ]
Reference: [1] Journal of Organic Chemistry, 1960, vol. 25, p. 708 - 711
  • 10
  • [ 6683-48-3 ]
  • [ 92050-16-3 ]
Reference: [1] Journal of Organic Chemistry, 1960, vol. 25, p. 708 - 711
  • 11
  • [ 108-88-3 ]
  • [ 92050-16-3 ]
Reference: [1] Journal of Organic Chemistry, 1960, vol. 25, p. 708 - 711
  • 12
  • [ 94497-53-7 ]
  • [ 92050-16-3 ]
Reference: [1] Organic Process Research and Development, 2017, vol. 21, # 5, p. 748 - 753
  • 13
  • [ 92050-16-3 ]
  • [ 94497-51-5 ]
Reference: [1] Journal of Medicinal Chemistry, 1988, vol. 31, # 11, p. 2182 - 2192
[2] Letters in Drug Design and Discovery, 2016, vol. 13, # 8, p. 729 - 733
  • 14
  • [ 92050-16-3 ]
  • [ 27452-17-1 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 2013, vol. 61, # 2, p. 237 - 241
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 92050-16-3 ]

Aryls

Chemical Structure| 116233-17-1

[ 116233-17-1 ]

3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-amine

Similarity: 0.97

Chemical Structure| 6373-50-8

[ 6373-50-8 ]

4-Cyclohexylaniline

Similarity: 0.97

Chemical Structure| 60532-63-0

[ 60532-63-0 ]

4,4',4'',4'''-Methanetetrayltetraaniline

Similarity: 0.94

Chemical Structure| 2479-47-2

[ 2479-47-2 ]

4,4'-(Propane-2,2-diyl)dianiline

Similarity: 0.94

Chemical Structure| 769-92-6

[ 769-92-6 ]

4-(tert-Butyl)aniline

Similarity: 0.94

Amines

Chemical Structure| 116233-17-1

[ 116233-17-1 ]

3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-amine

Similarity: 0.97

Chemical Structure| 6373-50-8

[ 6373-50-8 ]

4-Cyclohexylaniline

Similarity: 0.97

Chemical Structure| 60532-63-0

[ 60532-63-0 ]

4,4',4'',4'''-Methanetetrayltetraaniline

Similarity: 0.94

Chemical Structure| 2479-47-2

[ 2479-47-2 ]

4,4'-(Propane-2,2-diyl)dianiline

Similarity: 0.94

Chemical Structure| 769-92-6

[ 769-92-6 ]

4-(tert-Butyl)aniline

Similarity: 0.94